NCT06026995 2023-09-07
Clinical Study on PEG-rhG-CSF in Mobilizing Autologous Hematopoietic Stem Cells
Chongqing University Cancer Hospital
Phase 4 Unknown
Clinical Trials
11 trialsNCT05510544 2023-03-13
Plerixafor for Poorly Mobilized Lymphoma
Peking University
Phase 4 Unknown
NCT02526823 2019-04-02
Clinical Application of Polyethylene Glycol Liposome Doxorubicin (PLD) in Primary Lymphoma
Shandong Provincial Hospital
Phase 4 Unknown
NCT02933333 2018-10-17
G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 4 Unknown
NCT01765231 2017-01-10
Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma
Peking University
Phase 4 Unknown
NCT01768195 2017-01-10
Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy
Peking University
Phase 4 Unknown
NCT03010579 2017-01-05
Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation
Peking University
Phase 4 Unknown
NCT02576327 2016-12-30
A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation
Peking University
Phase 4 Unknown
NCT02929615 2016-10-12
Study of Standard and Individualized Treatment Model for Relapse and Refractory Lymphatic System Malignant Tumors
Peking University
Phase 4 Unknown
NCT02905942 2016-09-19
PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation
Peking University
Phase 4 Unknown
NCT02347878 2015-01-27
Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH)
Sun Yat-sen University
Phase 4 Unknown